$170 Million is the total value of KNOTT DAVID M's 135 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LGND | Sell | Ligand Pharmaceuticals Incorporated | $23,644,000 | -22.6% | 248,041 | -9.2% | 13.87% | -16.8% |
| SRCL | Sell | Stericycle, Inc. | $10,090,000 | -33.0% | 160,000 | -40.5% | 5.92% | -28.0% |
| KKR | Sell | KKR & Co. Inc. | $3,434,000 | -38.2% | 100,000 | -44.4% | 2.02% | -33.6% |
| Sell | Trillium Therapeutics Inc. | $2,504,000 | +17.1% | 176,215 | -33.3% | 1.47% | +25.9% | |
| CHRS | Sell | Coherus Biosciences, Inc. | $1,825,000 | -2.3% | 99,493 | -4.9% | 1.07% | +5.0% |
| BDSI | Sell | BioDelivery Sciences International, Inc. | $1,798,000 | -18.4% | 481,930 | -4.7% | 1.06% | -12.3% |
| ALKS | Sell | Alkermes PLC | $630,000 | -44.1% | 38,000 | -34.6% | 0.37% | -39.8% |
| COLL | Sell | Collegium Pharmaceutical, Inc. | $622,000 | -48.5% | 29,862 | -56.8% | 0.36% | -44.6% |
| CCXI | Sell | ChemoCentryx, Inc. | $361,000 | -91.6% | 6,587 | -91.2% | 0.21% | -91.0% |
| ADMA | Sell | ADMA Biologics, Inc. | $156,000 | -73.4% | 65,157 | -67.4% | 0.09% | -71.2% |
| CPRX | Exit | Catalyst Pharmaceuticals, Inc. | $0 | – | -42,117 | -100.0% | -0.11% | – |
| DELL | Exit | Dell Technologies Inc. | $0 | – | -6,426 | -100.0% | -0.19% | – |
| QTNT | Exit | Quotient Limited | $0 | – | -129,527 | -100.0% | -0.52% | – |
| BLU | Exit | BELLUS Health Inc. | $0 | – | -238,611 | -100.0% | -1.35% | – |
| FSK | Exit | FS KKR Capital Corp. | $0 | – | -395,175 | -100.0% | -3.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 34 | Q3 2021 | 52.6% |
| Pfizer Inc. | 34 | Q3 2021 | 17.4% |
| Capitol Federal S&L | 34 | Q3 2021 | 5.7% |
| JP Morgan Chase& Co. | 34 | Q3 2021 | 1.3% |
| Apple Inc. | 34 | Q3 2021 | 2.1% |
| Microsoft Corporation | 34 | Q3 2021 | 2.3% |
| AllianceBernstein Holdings PL Unit Ltd. | 34 | Q3 2021 | 0.9% |
| Johnson & Johnson | 34 | Q3 2021 | 0.6% |
| Mondelez Int'lt Inc. | 34 | Q3 2021 | 0.5% |
| Ryman Hospitality PPTYS Inc. | 34 | Q3 2021 | 0.4% |
View KNOTT DAVID M's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | February 13, 2018 | 865,500 | 4.1% |
| Rand Logistics, Inc. | November 15, 2017 | 1,432,660 | 7.2% |
| Essex Rental Corp. | August 16, 2013 | 1,124,472 | 4.5% |
| Westway Group, Inc. | February 01, 2013 | ? | ? |
| FutureFuel Corp. | February 01, 2012 | 1,838,000 | 4.5% |
| COLUMBIA LABORATORIES INC | January 31, 2012 | ? | ? |
| Essex Rental Corp. | February 16, 2011 | 2,805,666 | 13.0% |
| Pet DRx CORPSold out | February 09, 2011 | 0 | 0.0% |
| China Ceramics Co., Ltd | October 14, 2010 | 1,350,000 | 10.3% |
| NABI BIOPHARMACEUTICALS | June 22, 2010 | 2,344,597 | 4.8% |
View KNOTT DAVID M's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-13 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-12 |
| 13F-HR | 2019-08-12 |
View KNOTT DAVID M's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.